X @Bloomberg

Novo Nordisk Mike Doustdar lost out to Pfizer in a $10 billion takeover battle for obesity drug developer Metsera, but he's keeping deals on the table as the Danish company seeks to regain lost ground in the weight-loss boom. https://t.co/Xr0iZRYjpU ...